TransMedics Group, Inc.TMDXNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank11
3Y CAGR-27.8%
5Y CAGR-19.1%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-27.8%/yr
vs -14.7%/yr prior
5Y CAGR
-19.1%/yr
Recent deceleration
Acceleration
-13.2pp
Decelerating
Percentile
P11
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20256.80+33.2%
20245.10-54.1%
202311.12-38.5%
202218.09+0.0%
202118.09-7.6%
202019.57+62.6%
201912.04-64.7%
201834.09-18.2%
201741.70-19.7%
201651.91-